YEAR: 2020
What can we learn from each other? A multidisciplinary approach to PD – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
October 2020 - March 2021, online
Round Table Discussion: Anticoagulation for Cerebral Venous Thrombosis (organised by ORUEN)
Jan -June 2020, Online
Evidence-based Medicine in Mood Disorders
25-27 February 2020 , Copenhagen
Migraine Headache Management 2020: Time for Change
13-14 March 2020, Barcelona
Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease (organised by Oruen)
March - August 2020, online
MDD debate: New paradigms in major depressive disorder (with educational financial grant of Janssen Pharmaceutica)
26-27 May 2020, Barcelona
Improving the Management of Patients With Major Depressive Disorder: Patient case: A 27-year-old woman with recurrent major depressive disorder (on www.Med-Sims.org, with the financial support of Janssen Pharmaceutica NV)
01 May 2020 - 30 October 2020, Online
Improving the Management of Patients With Major Depressive Disorder: A 45-year-old male with recurrent major depressive disorder, generalized anxiety disorder, and multiple metabolic co-morbidities (on www.Med-Sims.org, with the financial support of Janssen Pharmaceutica NV)
01 May 2020 - 30 October 2020, Online
Improving the Management of Patients With Major Depressive Disorder: A 59-year-old university professor with recurrent major depressive disorder and subjective cognitive impairment (on www.Med-Sims.org, with the financial support of Janssen Pharmaceutica NV)
1 May 2020 - 30 October 2020 , Online
The impact of Covid-19 for families with Parkinson’s Disease, Bas Bloem (bu ORUEN)
May 2020 - November 2020, online
A2A Receptor Antagonists Potential adjuvant therapies for levodopa optimisation (by ORUEN)
May - November 2020, Online
New paradigms in major depressive disorder – Fast-acting treatments: A deep dive into the efficacy and tolerability data. Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (Programme available on 25 June 2020 - 25 June 2021)
25 June 2020, Online
MDD debate: New paradigms in major depressive disorder – Glutamatergic pathways and the challenges of treatment-resistant depression - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (Programme available on 17 June 2020 - 17 June 2021).
17 June 2020, Online
Managing MS during times of change: The COVID-19 pandemic Debate (With educational financial support provided by Merck)
11 June 2020, Online
Pregnancy and MS: Evolving care for MS patients (With educational financial support provided by Merck)
5 June 2020, Online
Nonmotor symptoms in Parkinson Disease, recognition and management – An interview with Professor Per Odin, Sweden (online course by Oruen)
June 2020 - December 2020, online
Impact of COVID-19 on patients with MDD and their management. Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (Programme available on 22 July 2020 - 22 July 2021)
July 2020-July 2021, Online
Satellite symposium at the 28th European Congress of Psychiatry (EPA) 2020: What is the ultimate goal of MDD treatment? (with educational financial grant of Lundbeck)
6 July 2020, Online
Expert-led webinar at the 28th European Congress of Psychiatry (EPA) 2020: How to achieve optimum outcomes for patients: Exploring the current and future landscape for schizophrenia management (with educational financial grant of Janssen Pharmaceutica)
7 July 2020, Online
Expert-led webinar at the EPA 2020: Moving towards new models and dimensional approaches in the management of major depressive disorder (with educational financial grant of Janssen Pharmaceutica)
6 July 2020, Online
Satellite symposium at the 28th European Congress of Psychiatry (EPA) 2020: Changing Course in MDD (with educational financial grant of Janssen Pharmaceutica)
5 July 2020, Online
Evidence-based Medicine in Schizophrenia (Virtual seminar, with educational financial support provided by the Lundbeck Institute)
30 September-01 October 2020, Online
MS digital management: Key learnings from changing times, virtual meeting (With educational financial support provided by Merck)
28 September 2020, Online
Shifting the Paradigm in the treatment of headache disorders (With educational financial support provided by Eli Lilly)
25 September 2020, Barcelona/Cairo (Connected & Hybrid Meetings)
Improving outcomes in the treatment of opioid dependence (IOTOD) virtual conference 2020
24 September - 26 September 2020 , Online
ECNP highlights: Insights into recent developments in MDD and TRD - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (Programme available on 16 September 2020 - 16 September 2021)
16 September 2020 , Online
An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion | Latest evidence and discussion (Online Round Table Discussion by ORUEN)
14 September 2020, Online
MDD and the COVID-19 pandemic: challenges and opportunities - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (Programme available on 11 September 2020 - 11 September 2021)
11 September 2020 , Online
Optimising outcomes in TRD based on new insights on the neurobiology of depression - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (One hour programme, available on 8 October 2020 - 8 October 2021)
8 October 2020, Online
Functional impact of migraine: an important consideration for preventive treatment (Industry-sponsored symposium on the occasion of the MTIS 2020, with educational financial support provided by H. Lundbeck A/S)
8 October 2020, Online
Role, Function, and Effect of Catechol-O-Methyl Transferase in Humans and Parkinson Disease (Interview of Fabrizio Stocchi, a programme by ORUEN)
October 2020 - March 2021, Online
Round Table Discussion : Living with Parkinson’s: The Impact of Treatment Choices. By Werner Poewe, Angelo Antonini, Pablo Mir (a programme by ORUEN)
October 2020 - March 2021, Online
MS EXPERIENCE SHARING PRACTICE COURSE Digital Learning Journey (With educational financial grant provided by Merck): Live webinar on 29 November 2020 (Multiple Sclerosis AcadeMe, organised by Meridiano Healthcare)
29 November 2020, Online
MS EXPERIENCE SHARING PRACTICE COURSE Digital Learning Journey (With educational financial grant provided by Merck): Live webinar on 28 November 2020 (Multiple Sclerosis AcadeMe, organised by Meridiano Healthcare)
28 November 2020, Online
MS EXPERIENCE SHARING PRACTICE COURSE Digital Learning Journey (With educational financial grant provided by Merck): Live webinar on 27 November 2020 (Multiple Sclerosis AcadeMe, organised by Meridiano Healthcare)
27 November 2020, Online
ONLINE BARTS-MS PRECEPTORSHIP: EARLY EFFECTIVE TREATMENT (Multiple Sclerosis AcadeMe, with educational financial grant provided by Merck, organised by Meridiano Healthcare)
26 November 2020, Online
ONLINE BARTS-MS PRECEPTORSHIP: Introduction and MS diagnosis (Multiple Sclerosis AcadeMe, with educational financial grant provided by Merck, organised by Meridiano Healthcare)
25 November 2020, Online
Changing targets, Expanding horizons: The next decade in MS (with educational financial support provided by Merck)
15 November 2020, Online
Shifting the Paradigm in the Treatment of Headache Disorders (with educational financial grant of Eli Lilly)
10 November 2020, Online
Building best practice in the TRD clinic: an experience exchange - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (One hour programme, available on 5 November 2020 - 5 November 2021)
5 November 2020, Online
Intelligence having fun: creativity as an outcome in PD – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Hope does not wear-OFF: Interview with The Michael J. Fox Foundation – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Motor complications across the globe – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021 , online
If I could turn back the clock: the search for an anti-ageing agent for PD – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Levodopa austerity: sparing or mining the gold standard? Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Opicapone across the full spectrum of motor fluctuations: latest data. Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
The pathophysiology of wearing-off and the current treatment alternative. Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Are we regenerating expectations about regenerative therapies for PD? Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
What can we learn from each other? A multidisciplinary approach to PD – Video presentation on the platform ‘Keep ON Learning’ (with educational financial grant of BIAL Pharmaceuticals)
November 2020 - April 2021, online
Duo interview with leading experts in Parkinson’s Disease : Prof. Bas Bloem interviewed by prof. Werner Poewe : Tailoring Levodopa according to patient characteristics (by ORUEN, with educational financial grant provided by BIAL)
November 2020 - April 2021, Online
Round Table Discussion : Motor Symptoms And Therapy Choices | Advanced Parkinson’s Disease, by
Bas Bloem, Per Odin and Olivier Rascol (a programme by ORUEN)
November 2020 - April 2021, Online
Towards a personalised approach in TRD management: clinician and patient perspectives - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (One hour programme, available on 10 December 2020 - 10 December 2021)
10 December 2020, Online
Building best practice in the TRD clinic: interactive case discussions - Webinar on the Janssen NSME Forum website, with educational financial grant of Janssen Pharmaceutica NV (One hour programme, available on 3 December 2020 - 3 December 2021)
3 December 2020 , Online
ONLINE BARTS-MS PRECEPTORSHIP: MANAGING SYMPTOMATIC PROBLEMS IN MS (Multiple Sclerosis AcadeMe, with educational financial grant provided by Merck, organised by Meridiano Healthcare)
2 December 2020 , Online
ONLINE BARTS-MS PRECEPTORSHIP: MANAGING ADVANCED OR PROGRESSIVE MS (Multiple Sclerosis AcadeMe, with educational financial grant provided by Merck, organised by Meridiano Healthcare)
1 December 2020, Online